Tumor burden (TB) and treatment exposure (TE) in patients (pts) with malignant pleural mesothelioma (MPM) receiving nintedanib (N)/placebo (P) in combination with first line …Sanjay Popat,Federica Grosso,Nicola Steele,Anna K Nowak,Silvia Novello,Laurent Greillier,Martin Reck,Tom John,Paul Taylor,Natasha B Leighl,Giovanni Luca Ceresoli,Jens Benn Sørensen,Nick Pavlakis,David Planchard,Brett Gordon Maxwell Hughes,Julien Mazieres,Mark A Socinski,Hannes Buchner,Jose Barrueco,Giorgio V Scagliottiuser-5ebe282a4c775eda72abcdce（2018）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
